chrisvoncsefalvay/vaers-outcomes huggingface dataset:
One of my colleagues decided it would be a good idea to engage in bare-chested wrestling with one of his comrades who had recently received the smallpox vaccination on 5/19/2008. (ACAM 2000). Patient subsequently had a eruption of vesicles to his chin, neck, and forearm yesterday, 6/8/08.  He was evaluated by the IDC on duty up  and started on Septra + Acyclovir PO.  Today, 6/9/08, the inadvertent vaccination has progressed so that his entire chin is covered with vesicles.  No lesions up near the eye or in the mouth.  He is non-toxic and lesions are not painful.  I discussed his case with another person up at the ED who did not think he needed to be admitted or any additional treatment was required. I have reviewed the guidance from regulatory authority and the CDC.  I would classify him as having a regional form of Generalized Vaccinia.  We have him under strict contact precautions and isolation in the barracks.  I am in contact with DERM for further guidance.
Patient states that she began with some nausea, fatigue, diarrhea a few days after receiving the vaccine.
This spontaneous report as received from a healthcare student refers to a 60 year old female patient. The patient's medical history included multiple sclerosis and respiratory problems. Patient had no drug reactions and allergies. On 23-JUN-2014 the patient was vaccinated with a dose of ZOSTAVAX, 0.65ml, subcutaneous. Concomitant therapies included levothyroxine sodium (manufacturer unknown), metoprolol, PROAIR, montelukast sodium (manufacturer unknown), simvastatin (manufacturer unknown), omeprazole (manufacturer unknown), escitalopram and carbamazepine. The reporter stated that the patient one month after, was diagnosed with shingles. He stated that she had another case of shingles afterwards, but there is no information as to when the second case occurred. The patient sought medical attention by office visit. No treatment was given for the event. There was no product quality complaint. No lab diagnostics studies were performed. The outcome of shingles was reported as recovered/resolved on an unknown date. The causality of the events was not specified by the reporter. Additional information has been requested.
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unkonwn age and genders. The reporter stated that, on an unspecified date, an unknown number of doses of PEDVAXHIB (dose, lot#, expiration dates not provided) that were stored at 48 degrees F for 20 minutes, then exposed to 47 degrees for 9 minutes have been administered. No adverse effects were reported. Follow up information has been received on 22-JUL-2014 from a receptionist. The reporter stated that there were two different lot number of PEDVAXHIB that were included in the temperature excursion: Lot # J016188, expiration date: 02-OCT-2016 and lot # J015437, expiration date: 09-OCT-2016. The receptionist did not have any additional information to share with Merck. Follow up information has been received from the registered nurse who provided patients' details. This report refers to a 9 weeks old infant patient of unknown gender. On 23-JUN-2014, the patient was vaccinated with a dose of PEDVAXHIB  lot number J015437, expiration date: 09-OCT-2016, (dose and route were not reported) that was improperly stored. No adverse effects reported. This is one of several reports received from the same reporter. Additional information is not expected because follow up has been obtained.
Initial reaction was similar to reaction of second dose: low fever, body aches, headache and exhaustion. New reaction: joint stiffness and pain. This lasted from 28 hours post-injection to 72 hours post-injection, but the joint stiffness, some body aches and exhaustion remained. Over the next three weeks, joint stiffness has mostly resolved, but exhaustion and some body aches remain.
On 3/15/21, nine days after my first Moderna Covid shot, I started having severe, sharp stabbing pains in my left inner ear, left outer ear and left jaw. They lasted only a second or two but were enough to stop me in my tracks. I also felt a "tickle" on the right side of my throat, which caused me to cough occasionally (Dry).  It happened 2-3 times on 3/15/21. The sharp searing, stabbing pains continued for about 24 more days. I saw my PCP on 3/18, who did 2 Covid tests, step test, RSV, and Flu tests, all of which were negative. At no time did I have a fever or body aches. She diagnosed a possible Sinus infection, but didn't really see anything alarming in my ear or throat. I took 4 days of Azithromycin with no improvement. I saw my PCP again on 3/22/21, again had negative Covid test, so she changed me to Doxycycline and Ciprodex ear drops. I took the full course of these, but had the sharp pains in  my ear and in addition the entire right side of my face and jaw and ear hurt constantly. Still no fever.  My PCP referred me to an ENT. I received my second Covid shot on 4/5/21. Fifteen hours after I had a fever to 102, and chills and nausea that lasted about 24 hours.  I felt fine by 4/7/21, and  never had any pain in my ear after my second shot.  On 4/12/21 I saw the ENT who sent me for blood work which showed that I had Shingles. Never did I have any visible lesions on my skin.
swollen throat; ears still feel swollen; ringing sound in ears; rash 8 days after second shot just like the first; debilitating headache; felt tired; swollen glands; close to dying; barely lift arms and legs; This spontaneous case was reported by a consumer and describes the occurrence of MOVEMENT DISORDER (barely lift arms and legs), FEAR OF DEATH (close to dying), PHARYNGEAL SWELLING (swollen throat), EAR SWELLING (ears still feel swollen) and TINNITUS (ringing sound in ears) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042L20A and 002A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Flu, Surgery and Broken bones. Concurrent medical conditions included Vein rupture (Patient is experiencing vein burst on his left wrist, stomach, sides and all other body parts.). Concomitant products included OXYCODONE HYDROCHLORIDE (OXYDONE BNM) from an unknown date to 01-May-2021 for Neck pain.   On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Jan-2021, the patient experienced MOVEMENT DISORDER (barely lift arms and legs). On 26-Feb-2021, the patient experienced FEAR OF DEATH (close to dying). On an unknown date, the patient experienced PHARYNGEAL SWELLING (swollen throat), EAR SWELLING (ears still feel swollen), TINNITUS (ringing sound in ears), RASH (rash 8 days after second shot just like the first), HEADACHE (debilitating headache), FATIGUE (felt tired) and LYMPHADENOPATHY (swollen glands). On 05-Feb-2021, MOVEMENT DISORDER (barely lift arms and legs) had resolved. On 08-Mar-2021, FEAR OF DEATH (close to dying) had resolved. At the time of the report, PHARYNGEAL SWELLING (swollen throat), EAR SWELLING (ears still feel swollen), TINNITUS (ringing sound in ears), RASH (rash 8 days after second shot just like the first), HEADACHE (debilitating headache), FATIGUE (felt tired) and LYMPHADENOPATHY (swollen glands) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 103.7 (High) 103.7.         No treatment medications were provided.    This case was linked to MOD-2021-220532 (Patient Link).
Itchy red rash with slight swelling and no bumps developed on several parts of body (primarily on hands but also on eyes, ears, legs, and belly) followed within 10 min by vomiting and within 20 min by chills and extreme fatigue. No fever present. Child was given 5 ml of Children's Zyrtec (5 mg Cetirizine HCl) and slept for one hour. After awakening, all symptoms were resolved. Symptoms and timing (about 48 hrs after) of post-vaccination adverse event were similar to mother's symptoms and timing upon receiving her Covid-19 vaccinations.
rt thigh-sl swollen, red raised rash 20x40mm over inj site; afeb; warm compresses & Advil ordered;
On Dec 3rd, I started feeling bad and the next day I went to urgent care. I took a home COVID-19 test. My temp went to 105.3 so I went to urgent care- they did a COVID-19 test and it was negative. I was having hard time breathing and they gave me a steroid shot. I went to my Doc the following week and he said I had either pneumonia or bronchitis. Recent health event: This past Friday 29th night, I was camping and the last thing I remember was from 18:30. The next day we went horseback riding at a certain point I wasn't able to remember the day /year anything around me. We went back to our camping site and we called the ambulance. This is all account from my girlfriend I was with because I don't remember anything. They took me to the ER on the helicopter. The first thing I remember was from Sunday May 1st. I was treated by the ambulance as if it was a blood clot/stroke.
TRANSIENT GLOBAL AMNESIA HOSPITALIZED.  RAN CT AND MRI SCANS - NOT ABLE TO FIND CAUSE. CAUSE UNKNOWN. NO TREATMENT.
stroke; brain bleed; vision was affected; This is a spontaneous report from Pfizer-sponsored program. A contactable consumer reported that a male patient (reporter's brother-in-law) of an unspecified age received BNT162B2 (Pfizer-BioNTech COVID-19 vaccine), via an unspecified route of administration on 2021 (lot number and expiry date was not reported) as dose 2, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that within 12 days of the patient's second shot, he had a brain bleed and a stroke on an unknown date in 2021. The patient was slowly getting better and there are things that are more of a struggle like his vision was affected. Retraining his brain has also been a bit of a challenge. The reporter states that they understand numerous factors could have caused this stroke and brain bleed, but, it was also a side effect of the vaccine and that they needed to report this. The outcome of the events stroke and brain bleed was recovering while the outcome of the event vision was affected was unknown.   The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Information has been received from a physicians assistant concerning a 40 year old female who was vaccinated with a dose of measles virus vaccine live  (Moraten) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) . The physician's assistant reported that a second dose status was unknown. On 21Nov03 the pt underwent a mumps immunoglobulin G antibody test, which was noted to be negative. The pt sought unspecified medical attention. The outcome of the pt's negative mumps titer was unknown. Additional information has been requested. The physician's assistant also reported a 28 year old female who received measles virus vaccine live  (Moraten) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3)  and developed a negative mumps titer.
pt became lightheaded and nauseated.  Elevated feet and given ice pack for neck.  Pulse 70, resp 16. rested for 30 minutes, feeling much better - able to ambulate without difficulty.  States she just feels a little off.  Husband came to take her home.
P/immun given client started to cry & then became apneic; PR noted 126; Apnea lasted only 15-20sec- raised lt arm & client responded imm; color ashen; DX w/hyperplastic heart: prognosis poor;
Pt developed disorientation and mental confusion for 5-6 days following influenza vaccination.
This case was reported by a pharmacist via call center representative and described the occurrence of pain in arm in an adult patient who received SHINGRIX for prophylaxis. Concurrent medical conditions included arthritis. On 7th January 2019, the patient received SHINGRIX. On 8th January 2019, 1 days after receiving SHINGRIX, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovering/resolving. It was unknown if the reporter considered the pain in arm to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was selected as adult as per vaccine indication. The patient, a day before date of reporting experienced aches in their arms and legs following vaccination. The patient had arthritis and was unsure if it was related to SHINGRIX or not. On the date of reporting, the patient reported that their symptoms were feeling a little better. The reporter consented to follow up.
This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, concomitant medications, drug reactions and allergies was provided. On 27-AUG-2018, the patient was vaccinated with an improperly stored dose of PROQUAD lot # R002939, expiration date: 29-JUL-2019 (strength, dose, route of administration and anatomical location were not reported) indicated for prophylaxis which was reconstituted with sterile diluent (MERCK) (lot# and expiration date not reported) properly stored. The administered dose of the vaccine PROQUAD experienced multiple temperature excursions of 6 degrees Fahrenheit (degree F) to 14 degrees Fahrenheit (degree F) for 303 minutes, as recorded by a data logger. There were no previous excursions reported. No adverse effects were reported. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1809USA002034: US-009507513-1809USA002036: US-009507513-1809USA002033: US-009507513-1809USA002037: US-009507513-1809USA001866: US-009507513-1809USA002032: US-009507513-1809USA002031.
Information has been received from a registered nurse concerning a patient of unknown age and gender. There was no information about concurrent condition, medical history or concomitant medication. The registered nurse reported that the patient had a measles, mumps, and rebella titer drawn on 10-MAY-2016 which showed low immunity to mumps. The nurse was unsure if the patient ever received M-M-R II (strength, dose, route and lot # unknown) prior to the titer. At the time of reporting, the outcome was unknown. The causality was not provided. This is one of several reports received from the same reporter. Additional information has been requested.
This spontaneous report as received from a pharmacist refers to 66 year old female patient. On 12-JUN-2013 the patient was vaccinated with a dose of ZOSTAVAX (0.65 ml, once, lot # H022153, exp. date 18-MAR-2013 subcutaneously) in the arm. On 12-JUN-2013, shortly after the patient received ZOSTAVAX she experienced huge bruise, 4 inches wide and run down patient's arm. It was reported that patient did not have any other adverse event. The patient sought medical attention via contacting pharmacist by phone. No treatment was given for adverse event. The outcome of patient's adverse event was not reported. The relatedness between ZOSTAVAX and patient's adverse event was not reported. Additional information has been requested.
have had 3 shots; shingles; vaccination failure; This spontaneous report was received from a patient of unknown age and gender reporting on himself via Glaxosmithkline.  The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On unknown dates, the patient received 3 doses of zoster vaccine live (ZOSTAVAX) subcutaneous injection, administered as prophylaxis (strength, dose description, lot #, expiry date, and route of administration were not provided) (reported as shingles vaccine). The first dose was years ago, when it became available and very expensive. In unknown dates in the last 3 years, the patient received the 2 series vaccine (Extra dose administered).   On an unknown date in March 2022 (reported as "this spring") , the patient developed shingles (Herpes zoster) (vaccination failure). The outcome of the events of herpes zoster and vaccination failure was not reported.    The causal relationship between herpes zoster and zoster vaccine live (ZOSTAVAX) was not reported. The event of vaccination failure was determined to be related to zoster vaccine live (ZOSTAVAX).
pt died at home; no medical records received on this patient; had a positive COVID test on 9/4/21; per death certificate, pt's cause of death was "COVID Pneumonia".
Patient was given 0.25mcg of Moderna Bivalent Booster not 0.5mcg, wrong dose was given to patient.
Presented to ED on 1/12/21 slowly worsening constant myalgias, generalized weakness where she couldn't walk, dry cough.  Per daughter not acting herself and more confused. Clinical impressions included hypoxia, COVID-19. Pt is s/p her first dose of vaccine and this precludes plasma. Supportive care steroids and doxy. Family faxed DNR on 1/12/21 at 2225. Remdesivir given 1/13/21 at 1am. 1/13/21 note at 1:30am: Pt's O2 sat fluctuating btw 80%-90%. Increased NC success pt O2 sat continues to decrease. NRB 15L in place O2 Sat 90%. Pt became pulseless and  expired at 0451.
None- vaccine given 6 days post expiry; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (None- vaccine given 6 days post expiry) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046C21A and 011L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (None- vaccine given 6 days post expiry). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (None- vaccine given 6 days post expiry) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication provided. No treatment medication provided.   This case was linked to MOD-2021-395985 (Patient Link).
Fainting, light headed, dizziness, pain in left calf, heavy legs, woozy, neck pain
Her arm is still swollen; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A female patient received (BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection), administration date 23Feb2021 (Batch/Lot number: unknown) as dose number unknown, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PERIPHERAL SWELLING (non-serious), outcome "not recovered", described as "Her arm is still swollen".  No follow-up attempts are possible. information about lot/batch number cannot been obtained. No further information is expected.
Pustules; bumps/itchy bumpy rash that spread to elbow; Right arm had normal soreness and aches  associated with a vaccine; heart was beating very fast and she felt it thumping that night; Headache; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PUSTULE (Pustules), RASH PRURITIC (bumps/itchy bumpy rash that spread to elbow), PAIN IN EXTREMITY (Right arm had normal soreness and aches  associated with a vaccine), PALPITATIONS (heart was beating very fast and she felt it thumping that night) and HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 03-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PUSTULE (Pustules), RASH PRURITIC (bumps/itchy bumpy rash that spread to elbow), PAIN IN EXTREMITY (Right arm had normal soreness and aches  associated with a vaccine), PALPITATIONS (heart was beating very fast and she felt it thumping that night), HEADACHE (Headache) and FATIGUE (Fatigue). The patient was treated with HYDROCORTISONE ACETATE (CORTISONE [HYDROCORTISONE ACETATE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, PUSTULE (Pustules), RASH PRURITIC (bumps/itchy bumpy rash that spread to elbow), PAIN IN EXTREMITY (Right arm had normal soreness and aches  associated with a vaccine), PALPITATIONS (heart was beating very fast and she felt it thumping that night), HEADACHE (Headache) and FATIGUE (Fatigue) outcome was unknown.            No Concomitant medications were provided.   This case was linked to MOD-2021-052069 (Patient Link).
A 12 year-old female patient (date of birth not reported) had received on an unspecified date a "common flu shot" (manufacturer, route and site of administration not reported) and an unspecified amount of time later developed Guillain-Barre syndrome. According to the parent, "it became chronic" and the patient now deals with CIDP. The patient lives in a college dorm. No further information was available at the time of the report. Outcome was not reported. Documents held by sender: none.
PATIENT STATES SHE HAS WEAKNESS IN HER ARM AND IT IS DIFFICULT FOR HER TO LIFT HEAVY OBJECTS. SHE ALSO IS HAVING PAIN DOWN TO HER WRIST.
People who are experiencing the same symptoms; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (People who are experiencing the same symptoms) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (People who are experiencing the same symptoms). At the time of the report, VACCINATION COMPLICATION (People who are experiencing the same symptoms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment medications were reported.   This case was linked to MOD-2021-406154, MOD-2021-405031, MOD-2021-406161, MOD-2021-406164 (Patient Link).
Patient complaint of feeling flushed, lightheaded, hot and having cotton mouth. Denied difficulty breathing and pain. 1609 vitals: T 98.2, P 83, O2 100%, R 18, BP 110/88. 1639 vitals T 98.4, P 76, O2 100%, R 16, BP 120/80. Patient feeling better and discharged from clinic.
Extreme soreness in arm & shoulder - could barely move my arm or sleep - followed the next day by overall body aches and fatigue - gradually improving - slight soreness in shoulder and fatigue continue at Day5